We are live on ! Find out more
CDLX icon

Cardlytics

117 hedge funds and large institutions have $712M invested in Cardlytics in 2019 Q3 according to their latest regulatory filings, with 46 funds opening new positions, 43 increasing their positions, 18 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

557% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 7

139% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 18

50% more funds holding

Funds holding: 78117 (+39)

45% more capital invested

Capital invested by funds: $491M → $712M (+$222M)

0.36% more ownership

Funds ownership: 8.37%8.73% (+0.36%)

20% less funds holding in top 10

Funds holding in top 10: 54 (-1)

Holders
117
Holders Change
+39
Holders Change %
+50%
% of All Funds
2.57%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.09%
New
46
Increased
43
Reduced
18
Closed
7
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$122M +$8.45M +26,370 +8%
CIP
2
CAS Investment Partners
Connecticut
$77.7M +$5.05M +15,739 +7%
Wellington Management Group
3
Wellington Management Group
Massachusetts
$65.8M +$51.3M +160,116 +444%
PVMCV
4
Polaris Venture Management Co V
Massachusetts
$50.5M -$24.7M -76,927 -34%
BlackRock
5
BlackRock
New York
$35.4M +$4.92M +15,334 +17%
Vanguard Group
6
Vanguard Group
Pennsylvania
$32.3M +$6.68M +20,834 +28%
Jennison Associates
7
Jennison Associates
New York
$23.6M -$15.4M -47,895 -41%
FCM
8
Frontier Capital Management
Massachusetts
$22.3M -$12.4M -38,804 -37%
AA
9
Antipodean Advisors
New York
$21.8M +$16.3M +50,764 +357%
Grantham, Mayo, Van Otterloo & Co (GMO)
10
Grantham, Mayo, Van Otterloo & Co (GMO)
Massachusetts
$13.4M
6CM
11
683 Capital Management
New York
$12.6M +$8.24M +25,711 +218%
DCM
12
Driehaus Capital Management
Illinois
$12.3M +$3.88M +12,100 +49%
Bank of America
13
Bank of America
North Carolina
$11M -$370K -1,154 -3%
JP Morgan Chase
14
JP Morgan Chase
New York
$9.7M +$2.89M +9,020 +45%
OCP
15
Oakcliff Capital Partners
New York
$9.42M +$9.01M +28,106 New
State Street
16
State Street
Massachusetts
$8.28M +$379K +1,182 +5%
Morgan Stanley
17
Morgan Stanley
New York
$7.77M +$7.01M +21,859 +1,658%
PC
18
Pier Capital
Connecticut
$7.6M +$7.27M +22,684 New
Geode Capital Management
19
Geode Capital Management
Massachusetts
$7.09M +$975K +3,041 +17%
PCM
20
Penn Capital Management
Pennsylvania
$6.91M +$6.6M +20,600 New
HRCM
21
Hood River Capital Management
Florida
$6.76M +$6.46M +20,163 New
Millennium Management
22
Millennium Management
New York
$6.29M +$3.9M +12,160 +184%
LCM
23
Landscape Capital Management
New Jersey
$6.24M +$5.96M +18,600 New
KCM
24
Kornitzer Capital Management
Kansas
$6.21M +$2.88M +8,971 +94%
UOC
25
UBS O'Connor
Illinois
$6.03M -$5.27M -16,435 -48%

CDLX Hedge Fund Activity: Q3 2019 in Review

117 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Cardlytics (CDLX) for Q3 2019, worth a combined $712M — up 45% from $491M a quarter earlier.

Buyers outnumbered sellers: 46 funds opened new CDLX positions and 7 closed out — a net gain of 39 holders — while 43 added to existing stakes and 18 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $51.3M. The largest seller was Canaan Partners VIII, exiting entirely with an estimated $29.4M sold.

  • 117 institutional investors held Cardlytics (CDLX) as of Q3 2019, up from 78 in Q2 2019.
  • Funds reported $712M of Cardlytics stock for Q3 2019, up 45% quarter-over-quarter.
  • 46 funds opened new Cardlytics positions in Q3 2019 and 7 closed out, a net change of +39 holders.
  • The largest Cardlytics buyer in Q3 2019 was Wellington Management Group, an estimated $51.3M added.
  • The largest Cardlytics seller in Q3 2019 was Canaan Partners VIII, an estimated $29.4M sold.

Based on aggregated 13F filings for Q3 2019.